Patient Voice, • 9/19/25 Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Previous How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Next Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials You Might Also Like Aligning Trials with Patient-Lived Experiences Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Leveraging Patient Advocacy To Scale Rare Disease Trials Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials
Patient Voice, • 9/19/25 Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Previous How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Next Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials You Might Also Like Aligning Trials with Patient-Lived Experiences Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Leveraging Patient Advocacy To Scale Rare Disease Trials Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials
